Table 3.
Adjusted percent change in aPWV by cystatin C, presence of CKD, and risk groupsa
| Parameter | Diabetes Present (n = 564)
|
Diabetes not Present (n = 1824)
|
White (n = 1475)
|
Black (n = 993)
|
CHD Present (n = 527)
|
CHD not Present (n = 1893)
|
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Percentage Change (95% CI) | P | Percentage Change (95% CI) | P | Percentage Change (95% CI) | P | Percentage Change (95% CI) | P | Percentage Chang (95% CI) | P | Percentage Change (95% CI) | P | |
| Cystatin C | ||||||||||||
| low (n = 454) | Reference | Reference | Reference | Reference | Reference | Reference | ||||||
| medium (n = 1497) | 10.1 (−0.6 to 22.0) | 0.060 | 4.6 (−0.4 to 9.9) | 0.070 | 6.5 (0.4 to 12.9) | 0.040 | 4.4 (−2.5 to 11.8) | 0.220 | 7.0 (−4.3 to 19.7) | 0.240 | 5.4 (0.5 to 10.6) | 0.030 |
| high (n = 517) | 11.1 (−1.6 to 25.4) | 0.090 | 8.0 (1.4 to 15.0) | 0.020 | 10.6 (2.9 to 18.8) | 0.006 | 4.5 (−4.5 to 14.4) | 0.330 | 10.7 (−2.8 to 25.9) | 0.120 | 7.9 (1.4 to 14.8) | 0.020 |
| CKD | ||||||||||||
| not present (n = 1934) | Reference | Reference | Reference | Reference | Reference | Reference | ||||||
| present (n = 533) | 6.7 (−2.4 to 16.7) | 0.150 | 0.2 (−4.2 to 4.8) | 0.950 | 2.2 (−2.5 to 7.1) | 0.360 | −0.7 (−8.1 to 7.3) | 0.860 | −0.2 (−8.6 to 8.9) | 0.960 | 2.1 (−2.4 to 6.8) | 0.370 |
a
Adjusted for age, gender, race, site, BMI, alcohol use, smoking, ACEI use, ARB use, prevalent congestive heart failure, prevalent CHD, diabetes, ankle arm index, triglycerides, LDL cholesterol, HDL cholesterol, C-reactive protein, Il-6, heart rate, PVD, SBP, and DBP.